Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Fabiana Barreira"'
Autor:
Maria-Jesus Pinazo, Colin J. Forsyth, Constanza Lopez-Albizu, Margarita María Catalina Bisio, Adriana González-Martínez, Laura Bohorquez, Jimy Pinto, Israel Molina, Andrea Marchiol, Rafael Herazo, Irene Losada Galván, Tayná Marques, Fabiana Barreira, Juan Carlos Villar, Yanina Sguassero, Maria Soledad Santini, Jaime Altcheh, Belkisyolé Alarcón de Noya, Sergio Sosa-Estani
Publikováno v:
Frontiers in Parasitology, Vol 2 (2023)
Trypanosoma cruzi infection is diagnosed by parasitological, molecular, and serological tests. Molecular methods based on DNA amplification provide a more sensitive alternative to classical parasitological techniques for detecting evidence of T. cruz
Externí odkaz:
https://doaj.org/article/b8bcff92341a4f9aa511d461f2c45320
Autor:
Brittany J Maguire, Prabin Dahal, Sumayyah Rashan, Roland Ngu, Anca Boon, Colin Forsyth, Nathalie Strub-Wourgaft, Eric Chatelain, Fabiana Barreira, Sergio Sosa-Estani, Philippe J Guérin
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 8, p e0009697 (2021)
BackgroundChagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6-7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support mo
Externí odkaz:
https://doaj.org/article/dcd21cb307b9408ea2efdc4b2c2c13ac
Autor:
Agustín Ciapponi, Fabiana Barreira, Lucas Perelli, Ariel Bardach, Joaquim Gascón, Israel Molina, Carlos Morillo, Nilda Prado, Adelina Riarte, Faustino Torrico, Isabela Ribeiro, Juan Carlos Villar, Sergio Sosa-Estani
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 14, Iss 8, p e0008529 (2020)
Chagas disease is a neglected disease that remains a public health threat, particularly in Latin America. The most important treatment options are nitroimidazole derivatives, such as nifurtimox and benznidazole (BZN). Some studies suggest that for ad
Externí odkaz:
https://doaj.org/article/dfa63decbe624f75ac4d6f62d5efe425
Autor:
Agustín Ciapponi, Fabiana Barreira, Lucas Perelli, Ariel Bardach, Joaquim Gascón, Israel Molina, Carlos Morillo, Nilda Prado, Adelina Riarte, Faustino Torrico, Juan Carlos Villar, Sara Reidel, Luz Gibbons, Sergio Sosa‐Estani
Publikováno v:
Tropical Medicine & International Health. 28:2-16
To determine the comparative efficacy and safety of a fixed dose of benznidazole (BZN) with an adjusted-dose for Trypanosoma cruzi-seropositive adults without cardiomyopathy.We conducted a systematic review and individual participant data (IPD) meta-
Autor:
Faustino Torrico, Joaquim Gascón, Lourdes Ortiz, Jimy Pinto, Gimena Rojas, Alejandro Palacios, Fabiana Barreira, Bethania Blum, Alejandro Gabriel Schijman, Michel Vaillant, Nathalie Strub-Wourgaft, Maria-Jesus Pinazo, Graeme Bilbe, Isabela Ribeiro
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Background Chagas disease (CD) has significant global health impact, but safe, effective treatments remain elusive. The nitroimidazole fexinidazole is a potential treatment. Methods This double-blind, randomized, placebo-controlled, dose-finding, pro
Autor:
Roland Ngu, Sergio Sosa-Estani, Anca Boon, Prabin Dahal, Philippe J Guerin, Sumayyah Rashan, Brittany J. Maguire, Eric Chatelain, Fabiana Barreira, Nathalie Strub-Wourgaft, Colin Forsyth
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 8, p e0009697 (2021)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Background Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support
Autor:
Jayme Fernandes, Igor Estevao, Joaquim Gascon, Isabela Ribeiro, Erika Correia, Rudy Parrado, Graeme Bilbe, Faustino Torrico, Gimena Rojas, Lourdes Ortiz, Daniel Lozano, Wilson Garcia, Uriel Ortega-Rodriguez, Alejandro Palacios, Roger Arteaga, Michel Vaillant, Katsura Hata, Lineth Garcia, Edgar Schuck, Fabiana Barreira, Cristina Alonso-Vega, Makoto Asada, Jimmy Pinto, Juan Carlos Ramirez, Tayná Barboza, Nathalie Strub-Wourgaft, María-Jesús Pinazo, Anabelle de la Barra, Bethania Blum, Maria Tays Mendes, Sergio Sosa-Estani, Alejandro G. Schijman, Igor C. Almeida, Ivana Martinez, Noritsugu Maki, Jhonny Camacho Borja
Publikováno v:
The Lancet. Infectious diseases. 21(8)
Current treatment for Chagas disease with the only available drugs, benznidazole or nifurtimox, has substantial limitations, including long treatment duration and safety and tolerability concerns. We aimed to evaluate the efficacy and safety of new b
Publikováno v:
The Lancet Infectious Diseases. 21:1067
Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America
Autor:
Fabiana Barreira, Peter J. Hotez, Maria Elena Bottazzi, Joaquim Gascon, Marcelo Abril, María-Jesús Pinazo, Julio Alonso-Padilla, Nuria Cortes-Serra, Sergio Sosa-Estani
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Introduction: Chagas disease, caused by infection with the parasite Trypanosoma cruzi, represents a huge public health problem in the Americas, where millions of people are affected. Despite the availability of two drugs against the infection (benzni
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.